Brokerages expect Senseonics Holdings Inc (NASDAQ:SENS) to announce earnings per share (EPS) of ($0.14) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Senseonics Holdings’ earnings, with estimates ranging from ($0.16) to ($0.12). Senseonics Holdings posted earnings of ($0.12) per share in the same quarter last year, which indicates a negative year-over-year growth rate of 16.7%. The firm is expected to report its next quarterly earnings report after the market closes on Tuesday, October 31st.

On average, analysts expect that Senseonics Holdings will report full year earnings of ($0.59) per share for the current financial year, with EPS estimates ranging from ($0.66) to ($0.52). For the next fiscal year, analysts anticipate that the company will report earnings of ($0.82) per share, with EPS estimates ranging from ($1.20) to ($0.43). Zacks’ earnings per share averages are an average based on a survey of research firms that follow Senseonics Holdings.

Senseonics Holdings (NASDAQ:SENS) last issued its earnings results on Wednesday, August 9th. The company reported ($0.12) earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.01. The company had revenue of $0.81 million for the quarter, compared to analysts’ expectations of $0.81 million.

Several equities research analysts have weighed in on the company. Canaccord Genuity reissued a “buy” rating on shares of Senseonics Holdings in a research note on Thursday, September 28th. Zacks Investment Research raised Senseonics Holdings from a “sell” rating to a “hold” rating in a research note on Tuesday, August 15th.

TRADEMARK VIOLATION NOTICE: “Zacks: Analysts Anticipate Senseonics Holdings Inc (SENS) to Post -$0.14 EPS” was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/10/22/zacks-analysts-anticipate-senseonics-holdings-inc-sens-to-post-0-14-eps.html.

Shares of Senseonics Holdings (NASDAQ:SENS) traded down 2.73% during midday trading on Friday, reaching $2.49. The company had a trading volume of 826,003 shares. The stock has a 50-day moving average of $3.04 and a 200 day moving average of $3.04. Senseonics Holdings has a 52 week low of $1.26 and a 52 week high of $3.67. The firm’s market capitalization is $306.77 million.

In other Senseonics Holdings news, COO Mukul Jain sold 11,885 shares of the business’s stock in a transaction that occurred on Monday, October 2nd. The stock was sold at an average price of $3.25, for a total transaction of $38,626.25. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Susquehanna International Group LLP bought a new stake in Senseonics Holdings during the second quarter worth approximately $155,000. Raymond James Financial Services Advisors Inc. grew its stake in shares of Senseonics Holdings by 221.4% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 263,562 shares of the company’s stock valued at $474,000 after buying an additional 181,562 shares during the last quarter. Goldman Sachs Group Inc. bought a new position in shares of Senseonics Holdings during the second quarter valued at approximately $276,000. LMR Partners LLP bought a new position in shares of Senseonics Holdings during the second quarter valued at approximately $177,000. Finally, NEA Management Company LLC grew its stake in shares of Senseonics Holdings by 27.1% during the second quarter. NEA Management Company LLC now owns 33,425,275 shares of the company’s stock valued at $60,165,000 after buying an additional 7,119,989 shares during the last quarter.

Senseonics Holdings Company Profile

Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.

Get a free copy of the Zacks research report on Senseonics Holdings (SENS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.